US-based medical device company Sutura has settled a patent infringement lawsuit with Abbott Laboratories.
Subscribe to our email newsletter
The settlement provides for a cross license of the Hathaway patents, licensed to Abbott by Indiana University, and the Sutura Nobles patents. In addition, Abbott has agreed to pay Sutura $23 million as part of the settlement agreement.
David Teckman, president and CEO of Sutura, said: “We now look forward to moving on with our continued enhancement of Sutura’s product line of vascular suturing devices, in particular the Sutura EL device.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.